Aragen Life Sciences Ltd.

This article introduces Aragen Life Sciences Ltd., an Indian biopharmaceutical company. The company is a CRO (contract research organization) that provides in-house R&D services, including non-clinical trials, and its core business is CRDMO services, which provide comprehensive support from the concept stage to commercialization. The following is a survey and summary of the characteristics of the company's contract non-clinical testing services.

Aragen Life Sciences Ltd.'s Contract Nonclinical Trial Services Feature

Possesses research facilities with GLP certification

Aragen Life Sciences Ltd. provides in-house research and development services, including non-clinical trials. The company's core business is CRDMO services, which provide total support for new drugs from the idea stage to commercialization, and it has business relationships with a large number of companies. To support this business, Aragen Life Sciences Ltd. has a research facility in Pune, India. This facility is GLP (Good Laboratory Practices) and AAALAC (Association for Assessment and Accreditation of Laboratory Animal Care) certified, and is also in line with OECD (Organization for Economic Cooperation and Development) standards.

Offering a wide range of services

Aragen Life Sciences Ltd. offers a wide range of services for both Small Molecules and Large Molecules (Biologics). Non-clinical trials are mainly positioned as "safety evaluation" in the early stages of drug discovery. In particular, safety evaluation is listed as a core service along with integrated drug discovery, chemistry, and biology in the small molecule drug discovery services. This is indicative of the company's desire to incorporate non-clinical testing from the earliest stages of the drug discovery process, leading to more efficient development.

Serving a diverse range of industries.

The company's non-clinical testing services are not limited to the pharmaceutical and biotech industries, but also serve the industrial chemical and agrochemical industries. The company's ability to serve such a diverse range of industries is due to its robust technical foundation and its expertise and flexibility in evaluating the safety of not only pharmaceuticals, but also a wide variety of chemicals and biotechnology products.

An example of Aragen Life Sciences Ltd.'s pathological model

The company offers a variety of pathological models, one example being a model to advance research on glioblastoma (glioblastoma / GBM). This model allows for the study of the disease and the validation of treatments by injecting human glioblastoma cells into the brain of a thymus-free nude mouse to create a tumor, thus enabling the study of the disease in conditions similar to those of human disease.

In addition, various other models of inflammation and pain are available, including a CFA-induced inflammatory pain model using rats.

Aragen Life Sciences Ltd. Non-clinical Case Studies

No specific case studies were available on the official website.

Aragen Life Sciences Ltd. Company Information

Aragen Life Sciences Ltd. has several offices in India as well as in the U.S., serving a variety of companies.